This clinical trial evaluates a communication intervention (TrialTalk™) for improving participation in clinical trials among White and African American cancer patients. TrialTalk™ is a communication tool that uses a pen-and-paper diagram to deliver information about different treatment options available for a patient's cancer diagnosis and the expected benefits, toxicities and life expectancy for each option. It promotes deliberation and patient engagement as the diagram is co-created in real-time between patients and doctors. TrialTalk™ may enhance communication between providers and patients and may increase the number of patients who consent to participate in a clinical trial for their cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06985953.
Locations matching your search criteria
United States
Wisconsin
Madison
University of Wisconsin Carbone Cancer Center - University HospitalStatus: Active
Contact: Monica Arun Patel
Phone: 608-265-1700
PRIMARY OBJECTIVE:
I. To evaluate TrialTalk™ effectiveness in promoting clinical trial accrual across White and African American patients.
SECONDARY OBJECTIVES:
I. To evaluate the implementation outcomes of TrialTalk™, such as adoption, penetration, fidelity, feasibility, and acceptability with different stakeholder groups.
II. To explore African American and White patients’ perceptions of the quality of communication and perceived trust in physicians following TrialTalk™ based consultations.
III. To examine the sustainment of TrialTalk™ intervention among enrolled providers at 12 months post-implementation.
OUTLINE:
Providers complete four TrialTalk™ training modules and then use the TrialTalk™ framework and tool in consultations that involve treatment discussions with patients.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationUniversity of Wisconsin Carbone Cancer Center - University Hospital
Principal InvestigatorMonica Arun Patel
